Eli Lillys booth at ASH 2025 prominently featuring Jaypirca
Pharma

Lilly’s BTK drug Jaypirca enters first-line CLL

Despite a positive first-line readout, Lilly’s Jake Van Naarden has maintained that the primary use of Jaypirca “remains in second line.”
Angus Liu Oct 2, 2026 4:15pm
Bayer Bayer Ohio New Albany

Bayer doubles down on US with $2.2B Ohio manufacturing project

Oct 2, 2026 3:10pm
Two hands with vitiligo holding each other

Litfulo and tilrekimig data bolster Pfizer's immunology plans

Oct 2, 2026 11:15am
Podcast
Graphic for The Top Line podcast featuring a pale blue background with a repeating pattern of blue-and-white capsules a

Locking in on pharma’s consumerization trend

Oct 2, 2026 10:36am
showdown clash versus vs crash lightning fight dispute

The Oral GLP-1 Tracker: Foundayo surges as Wegovy pill stalls

Oct 2, 2026 10:20am
Magnifying glass with pills on blue

Regulatory tracker: Camzyos wins pediatric nod at FDA

Oct 2, 2026 10:10am
More News

Teva, Samsung Bioepis deepen biosimilar bonds with new deal

Oct 2, 2026 10:00am

AZ-Summit, Novo-Hengrui, Merck—Fierce Pharma Asia

Oct 2, 2026 9:35am

Genentech amplifies breast cancer conversations in new campaign

Oct 1, 2026 2:52pm

Lilly dives deep into Foundayo's cardio perks in T2D, obesity

Oct 1, 2026 11:38am